EDITAS MEDICINE, INC. Other Income and Expense
EDITAS MEDICINE, INC. (EDIT) reported Other Income and Expense of $324.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-05
- EDITAS MEDICINE, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $324.00K.
- EDITAS MEDICINE, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $21.00K, a 72.00% decline year-over-year.
- EDITAS MEDICINE, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $2.13M, a 78.21% increase year-over-year.
- EDITAS MEDICINE, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was -$569.00K, a 116.14% decline year-over-year.
- EDITAS MEDICINE, INC. nonoperating income (expense) for fiscal 2025 was -$50.00K, a 100.36% decline from fiscal 2024.
- EDITAS MEDICINE, INC. nonoperating income (expense) for fiscal 2024 was $14.06M, a 11.92% decline from fiscal 2023.
- EDITAS MEDICINE, INC. nonoperating income (expense) for fiscal 2023 was $15.96M, a 189.27% increase from fiscal 2022.
- EDITAS MEDICINE, INC. nonoperating income (expense) for fiscal 2022 was $5.52M, a 756.83% increase from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $324.00K 10-Q · filed 2026-08-05 | $345.00K 10-Q · filed 2026-08-05 | $2.48M derived: sum of 3 quarters · filed 2026-08-05 | $1.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-05 | $2.16M derived: sum of 2 quarters · filed 2026-05-05 | $1.59M derived: sum of 3 quarters · filed 2026-05-05 | -$104.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.57M derived: sum of 2 quarters · filed 2026-03-09 | -$125.00K derived: sum of 3 quarters · filed 2026-08-05 | -$50.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | -$569.00K 10-Q · filed 2025-11-10 | -$2.26M derived: sum of 2 quarters · filed 2026-08-05 | -$2.19M 10-Q · filed 2025-11-10 | -$987.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.69M 10-Q · filed 2026-08-05 | -$1.62M 10-Q · filed 2026-08-05 | -$418.00K derived: sum of 3 quarters · filed 2026-08-05 | $3.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-05 | $1.27M derived: sum of 2 quarters · filed 2026-05-05 | $4.80M derived: sum of 3 quarters · filed 2026-05-05 | $9.09M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $4.72M derived: sum of 2 quarters · filed 2026-03-09 | $9.02M derived: sum of 3 quarters · filed 2026-03-09 | $14.06M 10-K · filed 2026-03-09 |
| 2024-09-30 | $3.52M 10-Q · filed 2025-11-10 | $7.82M derived: sum of 2 quarters · filed 2025-11-10 | $12.86M 10-Q · filed 2025-11-10 | $17.95M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $4.30M 10-Q · filed 2025-08-12 | $9.34M 10-Q · filed 2025-08-12 | $14.43M derived: sum of 3 quarters · filed 2025-08-12 | $19.57M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $5.04M 10-Q · filed 2025-05-12 | $10.13M derived: sum of 2 quarters · filed 2025-05-12 | $15.27M derived: sum of 3 quarters · filed 2025-05-12 | $19.08M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $10.23M derived: sum of 2 quarters · filed 2025-03-05 | $14.04M derived: sum of 3 quarters · filed 2025-03-05 | $15.96M 10-K · filed 2025-03-05 |
| 2023-09-30 | $5.14M 10-Q · filed 2024-11-04 | $8.95M derived: sum of 2 quarters · filed 2024-11-04 | $10.87M 10-Q · filed 2024-11-04 | $13.58M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $3.80M 10-Q · filed 2024-08-07 | $5.73M 10-Q · filed 2024-08-07 | $8.44M derived: sum of 3 quarters · filed 2025-03-05 | $10.23M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $1.93M 10-Q · filed 2024-05-08 | $4.63M derived: sum of 2 quarters · filed 2025-03-05 | $6.43M derived: sum of 3 quarters · filed 2025-03-05 | $7.21M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $4.50M derived: sum of 2 quarters · filed 2025-03-05 | $5.28M derived: sum of 3 quarters · filed 2025-03-05 | $5.52M 10-K · filed 2025-03-05 |
| 2022-09-30 | $1.79M 10-Q · filed 2023-11-03 | $2.58M derived: sum of 2 quarters · filed 2023-11-03 | $2.81M 10-Q · filed 2023-11-03 | $2.98M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $781.00K 10-Q · filed 2023-08-02 | $1.02M 10-Q · filed 2023-08-02 | $1.19M derived: sum of 3 quarters · filed 2024-02-28 | $1.36M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $235.00K 10-Q · filed 2023-05-05 | $409.00K derived: sum of 2 quarters · filed 2024-02-28 | $580.00K derived: sum of 3 quarters · filed 2024-02-28 | $725.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $345.00K derived: sum of 2 quarters · filed 2024-02-28 | $490.00K derived: sum of 3 quarters · filed 2024-02-28 | $644.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $171.00K 10-Q · filed 2022-11-02 | $316.00K derived: sum of 2 quarters · filed 2022-11-02 | $470.00K 10-Q · filed 2022-11-02 | $3.85M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $145.00K 10-Q · filed 2022-08-03 | $299.00K 10-Q · filed 2022-08-03 | $3.67M derived: sum of 3 quarters · filed 2022-08-03 | $2.50M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $155.00K 10-Q · filed 2022-05-04 | $3.53M derived: sum of 2 quarters · filed 2022-05-04 | $2.36M derived: sum of 3 quarters · filed 2022-05-04 | $10.13M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $3.38M 10-K · filed 2021-02-26 | $2.21M derived: sum of 2 quarters · filed 2021-11-09 | $9.97M derived: sum of 3 quarters · filed 2021-11-09 | $18.86M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$1.17M 10-Q · filed 2021-11-09 | $6.60M derived: sum of 2 quarters · filed 2021-11-09 | $15.49M 10-Q · filed 2021-11-09 | $17.14M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $7.77M 10-Q · filed 2021-08-05 | $16.66M 10-Q · filed 2021-08-05 | $18.31M derived: sum of 3 quarters · filed 2021-08-05 | $19.96M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $8.89M 10-Q · filed 2021-05-06 | $10.54M derived: sum of 2 quarters · filed 2021-05-06 | $12.19M derived: sum of 3 quarters · filed 2021-05-06 | $14.05M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.65M 10-K · filed 2021-02-26 | $3.30M derived: sum of 2 quarters · filed 2021-02-26 | $5.16M derived: sum of 3 quarters · filed 2021-02-26 | $7.18M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.65M 10-K · filed 2021-02-26 | $3.51M derived: sum of 2 quarters · filed 2021-02-26 | $5.52M 10-Q · filed 2020-11-06 | $6.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.86M 10-K · filed 2021-02-26 | $3.88M 10-Q · filed 2020-08-07 | $5.08M derived: sum of 3 quarters · filed 2021-02-26 | $6.09M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $2.01M 10-K · filed 2021-02-26 | $3.21M derived: sum of 2 quarters · filed 2021-02-26 | $4.23M derived: sum of 3 quarters · filed 2021-02-26 | $5.17M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $1.20M 10-K · filed 2020-02-26 | $2.22M derived: sum of 2 quarters · filed 2020-02-26 | $3.15M derived: sum of 3 quarters · filed 2020-02-26 | $3.77M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.02M 10-K · filed 2020-02-26 | $1.95M derived: sum of 2 quarters · filed 2020-02-26 | $2.58M 10-Q · filed 2019-11-12 | $2.83M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $934.00K 10-K · filed 2020-02-26 | $1.55M 10-Q · filed 2019-08-07 | $1.81M derived: sum of 3 quarters · filed 2020-02-26 | $1.96M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $620.00K 10-K · filed 2020-02-26 | $873.00K derived: sum of 2 quarters · filed 2020-02-26 | $1.02M derived: sum of 3 quarters · filed 2020-02-26 | $699.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $253.00K 10-K · filed 2019-03-01 | $403.00K derived: sum of 2 quarters · filed 2019-03-01 | $79.00K derived: sum of 3 quarters · filed 2019-03-01 | -$391.00K 10-K · filed 2020-02-26 |
| 2017-09-30 | $150.00K 10-K · filed 2019-03-01 | -$174.00K derived: sum of 2 quarters · filed 2019-03-01 | -$644.00K 10-Q · filed 2018-11-08 | -$1.04M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$324.00K 10-K · filed 2019-03-01 | -$794.00K 10-Q · filed 2018-08-07 | -$1.19M derived: sum of 3 quarters · filed 2019-03-01 | -$1.04M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$470.00K 10-K · filed 2019-03-01 | -$862.00K derived: sum of 2 quarters · filed 2019-03-01 | -$717.00K derived: sum of 3 quarters · filed 2019-03-01 | -$559.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$392.00K 10-K · filed 2018-03-08 | -$247.00K derived: sum of 2 quarters · filed 2018-03-08 | -$89.00K derived: sum of 3 quarters · filed 2018-03-08 | $5.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $145.00K 10-K · filed 2018-03-08 | $303.00K derived: sum of 2 quarters · filed 2018-03-08 | $397.00K 10-Q · filed 2017-11-08 | $137.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $158.00K 10-K · filed 2018-03-08 | $252.00K 10-Q · filed 2017-08-09 | -$8.00K derived: sum of 3 quarters · filed 2018-03-08 | -$31.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $94.00K 10-K · filed 2018-03-08 | -$166.00K derived: sum of 2 quarters · filed 2018-03-08 | -$189.00K derived: sum of 3 quarters · filed 2018-03-08 | -$37.36M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$260.00K 10-K · filed 2017-03-03 | -$283.00K derived: sum of 2 quarters · filed 2017-03-03 | -$37.46M derived: sum of 3 quarters · filed 2017-03-03 | -$37.59M 10-K · filed 2018-03-08 |
| 2015-09-30 | -$23.00K 10-K · filed 2017-03-03 | -$37.20M derived: sum of 2 quarters · filed 2017-03-03 | -$37.33M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$37.17M 10-K · filed 2017-03-03 | -$37.30M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$130.00K 10-K · filed 2017-03-03 | |||
| 2014-12-31 | -$962.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |